REGEND-004

N/A

Report date: 2024/04/24 10:40:18

Base Information

Drug NameREGEND-004
Drug Alias Name间皮细胞REGEND004REGEND-004
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangxi Xianhe Medical Technology Co LtdRegend Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRegend Therapeutics Co LtdJiangxi Xianhe Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A